Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113087650A reveals a high-yield, low-toxicity synthesis for 2-maleimidoacetic acid N-hydroxysuccinimide ester, offering significant cost and supply chain advantages.
Patent CN101314574B reveals a green aqueous method for acylated enamines using phosphotungstic acid, offering significant cost reduction and scalability for pharmaceutical intermediates.
Novel 8-step route for Bortezomib using isobutylboronic acid, eliminating column chromatography for cost-effective manufacturing.
Patent CN102994403A details a novel whole-cell biocatalytic route for (R)-2-hydroxy-4-phenylbutyric acid ethyl ester, offering superior stereoselectivity and cost efficiency for pharmaceutical manufacturing.
Novel polyionic liquid catalyst enhances yield and reduces waste for phenylpyruvic acid production offering supply chain stability and cost efficiency.
Patent CN112194603B reveals a green oxidation route for key HPPD inhibitor intermediates, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN1754963A details a solvent-free enzymatic route for pyroglutamic acid esters, offering high purity and cost-effective manufacturing for personal care suppliers.
Patent CN108752232B details a green photocatalytic method for alpha-quaternary amino acids using CO2, offering safer alternatives to toxic Strecker reactions for pharma supply chains.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel patent method for 2-hydroxyl 3 6-dichlorobenzoic acid reduces pressure requirements and enhances supply chain reliability for agrochemical manufacturers.
Patent CN108059621A details anhydrous butanone purification for 5-Methylpyrazine-2-Carboxylic Acid ensuring high purity and yield for reliable pharmaceutical intermediate supply chains.
Novel green synthesis route for fluoroquinolone intermediates offering high purity and scalable production capabilities for global pharma supply chains.
Patent CN108329194B reveals a novel binaphthol aluminum catalyst for citronellal cyclization, offering superior enantioselectivity and simplified industrial recovery.
Patent CN103319358B details a novel route for 7-aminoheptanoic acid. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing.
Novel synthesis patent CN118666668A offers high purity above 99% and scalable purification for pharmaceutical intermediates supply chain stability and cost efficiency in global manufacturing.
Patent CN100503590C details a novel Rh-catalyzed hydrogenation of L-malic acid diester. This method offers high optical purity and lower pressure conditions for efficient API intermediate manufacturing.
Advanced synthesis of N-3-isoxazole carbamic acid tert-butyl ester via patent CN109369553B. Delivers high purity, scalable production, and cost-effective supply chain solutions.
Discover the patented CN101817766A method for producing metanilic acid. Achieve 100% conversion with recyclable Pd/C catalysts, eliminating iron sludge and reducing costs for dye and pharma intermediates.
Advanced melt crystallization technology refines 2 5-FDCA from 5-HMF achieving over 99.5 percent purity. Ideal for PEF manufacturing with reduced aldehyde content.
Patent CN116903499B reveals a novel anhydrous copper salt synthesis enabling cost reduction in pharmaceutical intermediate manufacturing and high-purity trifluoromethylation.